BioAtla (BCAB) Other Non-Current Liabilities (2021 - 2026)

BioAtla's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $842000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 56.4% year-over-year to $842000.0 in Q1 2026; TTM through Mar 2026 was $842000.0, a 56.4% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 82.25% from the prior year.
• Other Non-Current Liabilities declined to $842000.0 in Q1 2026 per BCAB's latest filing, from $3.5 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $19.8 million in Q1 2022 and bottomed at $842000.0 in Q1 2026.
• The 5-year median for Other Non-Current Liabilities is $19.8 million (2022), against an average of $15.4 million.
• Across the five-year window, Other Non-Current Liabilities changed 0.0% in 2022 and slumped 90.25% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $19.8 million in 2022, then changed by 0.0% to $19.8 million in 2023, then changed by 0.0% to $19.8 million in 2024, then sank by 82.25% to $3.5 million in 2025, then sank by 76.05% to $842000.0 in 2026.
• Per Business Quant, the three latest BCAB Other Non-Current Liabilities figures stand at $842000.0 (Q1 2026), $3.5 million (Q4 2025), and $19.8 million (Q3 2025).